Drugplain

Albuterol Sulfate 2.5 mg/3mL

Albuterol Sulfate · SOLUTION · Nephron Pharmaceuticals Corporation

10 Recalls on RecordCurrently in Shortage
Plain English

Albuterol sulfate is a rescue inhaler medication used to quickly relieve airway constriction and wheezing in people with asthma, COPD, or other breathing conditions. This inhalation solution works by relaxing the muscles in the airways to help you breathe more easily during an asthma attack or breathing emergency.

Key Facts

Brand Name
Albuterol Sulfate
Generic Name
Albuterol Sulfate
NDC Code (Product)
0487-9501
Manufacturer
Nephron Pharmaceuticals Corporation
Strength
2.5 mg/3mL
Dosage Form
SOLUTION
Route
RESPIRATORY (INHALATION)
Marketing Status
Application #
ANDA074880
Marketing Start
09/17/1997

Recall History

10 Recalls on Record
Class II07/26/2012

GlaxoSmithKline Inc

Does Not Deliver Proper Metered Dose: Potential content of albuterol per dose is below specification.

TerminatedVoluntary: Firm initiated
Class II04/13/2022

Mckesson Medical-Surgical Inc. Corporate Office

cGMP deviations: Temperature abuse

TerminatedVoluntary: Firm initiated
Class II09/16/2020

Perrigo Company PLC

Defective Delivery System: Sustained trend of failure to dispense complaints.

TerminatedVoluntary: Firm initiated
Class II04/13/2022

Mckesson Medical-Surgical Inc. Corporate Office

cGMP deviations: Temperature abuse

TerminatedVoluntary: Firm initiated
Class II04/13/2022

Mckesson Medical-Surgical Inc. Corporate Office

cGMP deviations: Temperature abuse

TerminatedVoluntary: Firm initiated
Class II03/22/2017

GlaxoSmithKline, LLC

Defective Delivery System: Elevated number of units with out of specification results for leak rate.

OngoingVoluntary: Firm initiated
Class III07/24/2025

Cipla USA, Inc.

Failed Stability Specifications: Out of specification results was observed in Induction Port during the analysis of Particle size distribution at the 12-month time point.

OngoingVoluntary: Firm initiated
Class II11/14/2014

Attix Pharmaceuticals

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

TerminatedVoluntary: Firm initiated
Class II10/02/2013

Nephron Pharmaceuticals Corp.

Lack of Assurance of Sterility: Nephron Pharmaceuticals Corporation conducted a routine periodic aseptic process simulation and discovered bacterial growth in a number of media fill vials, exceeding the allowable limit.

TerminatedVoluntary: Firm initiated
Class II03/17/2026

Nephron SC, LLC

Labelling: Illegible label

OngoingVoluntary: Firm initiated

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

dyspnoea12,820 reports
wrong technique in product usage process10,595 reports
no adverse event8,282 reports
device delivery system issue7,807 reports
drug dose omission by device7,509 reports
asthma6,732 reports
cough6,067 reports
drug ineffective5,343 reports
fatigue4,915 reports
product dose omission issue4,752 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

1 INDICATIONS AND USAGE Albuterol Sulfate HFA is a beta 2 -adrenergic agonist indicated for: Treatment or prevention of bronchospasm in adult and pediatric patients aged 4 years and older with reversible obstructive airway disease. ( 1.1 ) Prevention of exercise-induced bronchospasm in adult and pediatric patients aged 4 years and older. ( 1.2 ) 1.1 Bronchospasm Albuterol Sulfate HFA Inhalation Aerosol is indicated for the treatment or prevention of bronchospasm in adult and pediatric patients aged 4 years and older with reversible obstructive airway disease. 1.2 Exercise-Induced Bronchospasm Albuterol Sulfate HFA is indicated for the prevention of exercise-induced bronchospasm in adult and pediatric patients aged 4 years and older.

Dosage & Administration

2 DOSAGE AND ADMINISTRATION For oral inhalation only. ( 2 ) Treatment or prevention of bronchospasm in adult and pediatric patients aged 4 years and older: 2 inhalations by oral inhalation every 4 to 6 hours. For some patients, 1 inhalation every 4 hours may be sufficient. ( 2.1 ) Prevention of exercise-induced bronchospasm in adult and pediatric patients aged 4 years and older: 2 inhalations by oral inhalation 15 to 30 minutes before exercise. ( 2.2 ) Priming information: Prime Albuterol Sulfate HFA before using for the first time, when the inhaler has not been used for more than 2 weeks, or when the inhaler has been dropped. To prime Albuterol Sulfate HFA, release 4 sprays into the air away from the face, shaking well before each spray. ( 2.3 ) Cleaning information: At least once a week, wash the actuator with warm water and let it air-dry completely. ( 2.3 ) 2.1 Recommended Dosage for Bronchospasm (Acute Episodes or Symptoms Associated with Bronchospasm) Adult and pediatric patients aged 4 years and older: 2 inhalations by oral inhalation repeated every 4 to 6 hours; in some patients, 1 inhalation every 4 hours may be sufficient. More frequent administration or a greater number

Contraindications

4 CONTRAINDICATIONS Albuterol Sulfate HFA is contraindicated in patients with a history of hypersensitivity to any of the ingredients [see Warnings and Precautions ( 5.6 ), Description ( 11 )] . Hypersensitivity to any ingredient. ( 4 )

Drug Interactions

7 DRUG INTERACTIONS Other short-acting sympathomimetic aerosol bronchodilators should not be used concomitantly with albuterol. If additional adrenergic drugs are to be administered by any route, they should be used with caution to avoid deleterious cardiovascular effects. Beta-blockers: Use with caution. May block bronchodilatory effects of beta-agonists and produce severe bronchospasm. ( 7.1 ) Diuretics: Use with caution. Electrocardiographic changes and/or hypokalemia associated with non–potassium-sparing diuretics may worsen with concomitant beta-agonists. ( 7.2 ) Digoxin: May decrease serum digoxin levels. Consider monitoring digoxin levels. ( 7.3 ) Monoamine oxidase inhibitors and tricyclic antidepressants: Use with extreme caution. May potentiate effect of albuterol on vascular system. ( 7.4 ) 7.1 Beta-Adrenergic Receptor Blocking Agents Beta-blockers not only block the pulmonary effect of beta-agonists, such as albuterol sulfate HFA, but may also produce severe bronchospasm in patients with asthma. Therefore, patients with asthma should not normally be treated with beta-blockers. However, under certain circumstances, there may be no acceptable alternatives to the use of bet

Adverse Reactions

6 ADVERSE REACTIONS The following clinically significant adverse reactions are described elsewhere in the labeling: Paradoxical bronchospasm [see Warnings and Precautions ( 5.1 )] Cardiovascular effects [see Warnings and Precautions ( 5.4 )] Hypersensitivity reactions, including anaphylaxis [see Warnings and Precautions ( 5.6 )] Hypokalemia [see Warnings and Precautions ( 5.8 )] Most common adverse reactions (incidence ≥3%) are throat irritation, viral respiratory infections, upper respiratory inflammation, cough, and musculoskeletal pain. ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Prasco Laboratories at 1-866-525-0688 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared with rates in the clinical trials of another drug and may not reflect the rates observed in practice. The safety data described below reflects exposure to albuterol sulfate HFA in 248 subjects treated with albuterol sulfate HFA in 3 placebo-controlled clinical trials of 2 to 12 weeks’ duration. The data from adults

Frequently Asked Questions

What is Albuterol Sulfate used for?

Albuterol sulfate is a rescue inhaler medication used to quickly relieve airway constriction and wheezing in people with asthma, COPD, or other breathing conditions. This inhalation solution works by relaxing the muscles in the airways to help you breathe more easily during an asthma attack or breathing emergency.

Is Albuterol Sulfate a controlled substance?

Albuterol Sulfate is not classified as a controlled substance by the DEA.

What is the generic name for Albuterol Sulfate?

The generic name for Albuterol Sulfate is Albuterol Sulfate. There are 9 other brand versions of Albuterol Sulfate.

What is the NDC code for Albuterol Sulfate 2.5 mg/3mL?

The NDC (National Drug Code) for Albuterol Sulfate 2.5 mg/3mL is 0487-9501, listed by Nephron Pharmaceuticals Corporation.